Where can multimodal AI take us?” he asked his audience last Monday. “You can get into a much different level of precision and accuracy medicine going forward,” he predicted. “For example, hospital-at ...

I know it won’t feel like it based on the decisions I’m taking today, but I really do care about this and so does this Government." ...

The government said it has taken advice to stop prescribing puberty blockers to children under 18 following a review into children's gender care. | ITV National News ...

The companies plan to integrate and pilot their combined technologies to gain insight into improving cardiovascular care.

The ban will prevent prescribing medications that can suppress or pause puberty in children with gender dysphoria ...

Ban does not apply to those already receiving drugs for gender dysphoria, treatment of children with rarely diagnosed ...

Wednesday’s announcement that the ban on sale and supply of puberty blockers through private prescriptions for under-18s is ...

Chimerix’s dordaviprone shows potential for glioma treatment with a possible FDA approval by 2025. Read why CMRX stock is a ...

The decision comes as the Supreme Court hears oral arguments for U.S v. Jonathan Skrmetti, a case which will determine the ...

In the absence of full guidelines, this expert consensus decision pathway gives practical advice for clinicians.

Health Secretary Wes Streeting announced an indefinite ban on puberty blockers for under-18s with gender dysphoria (Ben ...